Stay updated on Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial page.

Latest updates to the Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1. No substantive changes to the study details page were detected.SummaryDifference0.0%

- Check21 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no changes to the study data or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedThe page now shows a glossary and the 'Last Update Submitted that Met QC Criteria' entry, and includes 'No FEAR Act Data' along with the revision note 'v3.4.0' (replacing 'v3.3.4').SummaryDifference0.2%

- Check42 days agoChange DetectedA minor revision update from v3.3.3 to v3.3.4 appears in the page's record history; no changes to study content or eligibility criteria are observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a dedicated Locations section with Maryland listed as a site, and updated the revision tag; the previous Maryland Locations entry and older revision tag were removed.SummaryDifference0.2%

- Check92 days agoChange DetectedRevision label on the page was updated from v3.2.0 to v3.3.2; no substantive changes to the study details or navigation were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial page.